ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

VER Vernalis

6.17
0.00 (0.00%)
Last Updated: 01:00:00
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Vernalis LSE:VER London Ordinary Share GB00B3Y5L754 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 6.17 - 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

Vernalis Share Discussion Threads

Showing 1676 to 1696 of 3850 messages
Chat Pages: Latest  70  69  68  67  66  65  64  63  62  61  60  59  Older
DateSubjectAuthorDiscuss
30/9/2007
22:47
Mike, thanks. Good to see my prediction of failure for VER's application appearing to come true.

VOW, I did warn you. At least you said you didn't mind losing your money if it all went wrong; and I know you always invest on margin, so I guess you will lose considerably more than you invested.

I doubt if VER shares are now even worth 15p.

:-)

qazwsx123
30/9/2007
15:11
Thanks for that. I am surprised by that as it seemed fairly certain but have moved my stop today to respond to any mark down tomorrow.
vow
28/9/2007
18:08
VOW, I doubt it.
qazwsx123
28/9/2007
13:11
You could so easily be talking about AZM the way it is going.
vow
28/9/2007
12:57
VOW, by next week VER may have fallen to 30p, and if the news is bad they won't be worth anything imo.
qazwsx123
28/9/2007
09:04
So it looks like we will here from the FDA next week then.
vow
27/9/2007
10:51
The falling share price looks like some bad news may have leaked.
qazwsx123
27/9/2007
09:46
Lets hope the FDA don't pull a funny on Frova - should we hear Friday or wait until Monday?
fhmktg
26/9/2007
23:13
mach6, you're welcome

P.S.
Do you get the impression that VOW and the_doctor are one in the same?

qazwsx123
26/9/2007
19:59
Thanks QAZ.
mach6
26/9/2007
15:55
mach6, I could not see any reason to buy at that price. If they fall into the 20's it would probably be because they are only worth in the 10's.
qazwsx123
25/9/2007
20:36
QAZ, these seem to be heading towards the high 20`s, would you be a buyer at this level?
mach6
21/9/2007
14:47
VOW, don't pretend you are not disappointed that IC only rate VERNALIS as "Fair value" today.
qazwsx123
21/9/2007
14:42
Thanks for the heads up on the IC article.

According to them approval is "expected" on the 30th, which is more than I knew. This also triggers an instant £20m milestone payment, which will see the company through through 2008.

Turnover is up 23% on last year, which in this climate is not bad going.

I thought it to be 50/50 so my bet is looking better than before.

PS Qaz is only here to try and taunt me so best ignore him.

vow
21/9/2007
13:34
I doubt it. At best it will be lower by then and at worst could collapse on a refusal or more delays on 30th.

Have they managed to address all the safety issues?

qazwsx123
21/9/2007
12:06
That should ensure a good jump if the news is OK on 30th
fhmktg
21/9/2007
11:18
Vernalis shares only rated as "Fair value" in Investors Chronicle today ahead of the FDA decision, whereas IC tipped AZM as a "Buy" in July and at a higher price (97p) than today!

AZM should receive a lot more cash upfront from their expected "transforming deals in 2007" than Vernalis will in the coming months and through 2008 imo!

qazwsx123
20/9/2007
18:03
Vernalis are going to be Pipped by Meldex (Bioprogress old name)

DBP117 - Anti-Migraine

As previously announced, BioProgress is developing a triptan drug within its Soluleaves™ and Wafertab™ technology platforms. New manufacturing techniques have been developed, taken from the development work carried out on its DBP121 smoking cessation program. The product is entering into commercial scale up during Q4 2007. It is anticipated that revenues will be generated from partnership deals early in 2008.

From new market assessments and data, BioProgress has increased its revenue expectations to reach 3% of the global $3.1billion triptan market, increased from 1-1.5%

daveperry
18/9/2007
14:42
Rutter

British Bio (BB)was one of the three main companies which make up VER. VER bought up the parts of BB left after the discredited drug trial. The trial destroyed BB and lost the PI's a lot of money. I felt sorry for the guy who had to reveal the flawed science and the staff who lost their jobs. I met the CEO at Oxford and was concerned before the S... h.. the F.. .

I was lucky because I sold my shares at a reasonable profit. I have always emphasised the importance of seeing the management face to face at AGM's,etc if possible. It is a very important element in my research and in deciding top ups or to pull out.

Hope this helps.

mwryder
18/9/2007
13:44
Anyone. Has this company anything to do with what was once British Biotech. and what happened to Brit.Bio. TIA
rutter
18/9/2007
13:44
Anyone. Has this company anything to do with what was once British Biotech. and what happened to Brit.Bio. TIA
rutter
Chat Pages: Latest  70  69  68  67  66  65  64  63  62  61  60  59  Older

Your Recent History

Delayed Upgrade Clock